Shinichi Aishima

Prof. Dr. Shinichi Aishima


Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2007 in Journal of Computer Assisted Tomography
Verified
Journal Article
Closed access
YAYoshiki Asayama
Yoshiki Asayama
KYKengo Yoshimitsu
Kengo Yoshimitsu
HIHiroyuki Irie
Hiroyuki Irie
YNYunosuke Nishihara
Yunosuke Nishihara
SAShinichi Aishima
Shinichi Aishima
HHHiroshi Honda
Hiroshi Honda
To determine the vascularity of moderately and poorly differentiated hepatocellular carcinoma (mHCC and pHCC, respectively) as observed on and depicted by computed tomography during hepatic angiography and to perform pathological correlation. Eighty-seven consecutive patients with 89 hepatocellular carcinomas (61 mHCCs and 28 pHCCs) were surgically resected in our hospital. The degree of contrast enhancement on computed tomography during hepatic angiography of the tumors was classified into high attenuation (H), isoattenuation (I), and low attenuation (L). We also examined hepatocellular carcinomas measuring less than 4 cm in diameter. Pathologically, the number of unpaired arteries in the tumors was determined (×200 magnification). The number of mHCC and pHCC in each degree of enhancement (H/I/L) was 59:1:1 and 19:6:3, respectively. The number of mHCC and pHCC measuring less than 4 cm without portal invasion was 48 and 15, respectively; the number of these tumors in each degree of enhancement (H/I/L) was 47:1:0 and 11:3:1, respectively. The mean number of unpaired arteries was 8.9 ± 4.4 in mHCC and 5.2 ± 4.3 in pHCC, respectively. All results were statistically significant (P < 0.01). Our results indicated that the arterial blood supply of pHCC was lower than that of mHCC.

1 September 2014 in American Journal of Clinical Pathology
Verified
Journal Article
Open access
PDF file
YMYohei Mano
Yohei Mano
SAShinichi Aishima
Shinichi Aishima
YKYuichiro Kubo
Yuichiro Kubo
YTYuki Tanaka
Yuki Tanaka
TMTakashi Motomura
Takashi Motomura
YOYoshinao Oda
Yoshinao Oda
Objectives:. This study investigated the association between several biological markers and fluorine-18 fluorodeoxyglucose (FDG) uptake in patients wit

25 April 2024 in Hepatology Research
Verified
Journal Article
Closed access
Kazuhiro NousoKazuhiro Nouso
Kazuhiro Nouso
MKMiwa Kawanaka
Miwa Kawanaka
HFHideki Fujii
Hideki Fujii
KKKazuya Kariyama
Kazuya Kariyama
HTHidenori Toyoda
Hidenori Toyoda
J(Japan Study Group of Nonalcoholic Fatty Liver Disease (JSG‐NAFLD)
Japan Study Group of Nonalcoholic Fatty Liver Disease (JSG‐NAFLD)

3 April 2025 in Gels
Verified
Journal Article
Open access
PDF file
WLWU Lichun
WU Lichun
ZYZHOU YU
ZHOU YU
YZYi Zhang
Yi Zhang
JHJia Hu
Jia Hu
Yasuhiro IkegamiYasuhiro Ikegami
Yasuhiro Ikegami
HIHiroyuki Ijima
Hiroyuki Ijima
As dressings for moist wound healing, hyaluronic acid hydrogels play a significant role in maintaining moisture and promoting wound healing. However, existing hydrogel dressings are inadequate in terms of slow gelation time, weak mechanical performance, and fast degradation, which increases the risk of secondary infections during treatment. Therefore, we developed a hyaluronic acid double network hydrogel (DNH). Compared to single-network hydrogels (hydrazone and Diels–Alder), DNH shows a short gelation time (25 s) and strong mechanical properties (Young’s modulus = 82 kPa). These advantages enable DNH to immediately fill the irregular shape of the wound after gelation and remain intact after being squeezed. Swelling tests indicated that DNH had a suitable swelling ratio and maintained its structural integrity after swelling. We evaluated the use of DNH as a moist dressing for full-thickness wound healing in vivo. DNH-treated wounds healed faster, with enhanced blood vessel formation and macrophage polarization than gauze-treated wounds. These findings suggest that DNH not only accelerates wound healing but also improves tissue regeneration. Therefore, DNH may be a suitable moist dressing for wound healing.

1 July 2007 in Human Pathology
Verified
Journal Article
Closed access
YKYousuke Kuroda
Yousuke Kuroda
SAShinichi Aishima
Shinichi Aishima
ATAkinobu Taketomi
Akinobu Taketomi
YNYunosuke Nishihara
Yunosuke Nishihara
TITomohiro Iguchi
Tomohiro Iguchi
MTMasazumi Tsuneyoshi
Masazumi Tsuneyoshi

2 August 2021 in Scientific Reports
Verified
Journal Article
Open access
PDF file
SKSyunichiro Kimura
Syunichiro Kimura
KTKenichi Tanaka
Kenichi Tanaka
SOSatoshi Oeda
Satoshi Oeda
KIKaori Inoue
Kaori Inoue
CIChika Inadomi
Chika Inadomi
Hirokazu TakahashiHirokazu Takahashi
Hirokazu Takahashi
The effect of the skin–capsular distance (SCD) on the controlled attenuation parameter (CAP) for diagnosis of liver steatosis in patients with nonalcoholic fatty liver disease (NAFLD) remains unclear. The SCD was measured using B-mode ultrasound, and the CAP was measured using the M probe of FibroScan®. According to the indications of the M probe, 113 patients with an SCD of ≤ 25 mm were included in the present study. The association between the SCD and CAP was investigated, and the diagnostic performance of the SCD-adjusted CAP was tested. The SCD showed the most significant positive correlation with the CAP (ρ = 0.329, p < 0.001). In the multiple regression analysis, the SCD and serum albumin concentration were associated with the CAP, independent of pathological liver steatosis. According to the multivariate analysis, two different formulas were developed to obtain the adjusted CAP using the SCD and serum albumin concentration as follows: adjusted CAP (dB/m) = CAP − (5.26 × SCD) and adjusted CAP (dB/m) = CAP − (5.35 × SCD) − (25.77 × serum albumin concentration). The area under the receiver operating characteristic curve for diagnosis of a steatosis score ≥ 2 of adjusted CAP was 0.678 and 0.684 respectively, which were significantly greater than the original CAP (0.621: p = 0.030 and p = 0.024). The SCD is associated with the CAP independent of liver steatosis. Adjustment of the CAP using the SCD improves the diagnostic performance of the CAP in NAFLD.